Case Report: The Role of Neuropsychological Assessment and Imaging Biomarkers in the Early Diagnosis of Lewy Body Dementia in a Patient With Major Depression and Prolonged Alcohol and Benzodiazepine Dependence

Dementia with Lewy bodies (DLB) is the second most common form of dementia and is assumed to be often under- or misdiagnosed, especially in early stages. Here we present a complex case of probable DLB with major depression and alcohol and benzodiazepine dependence in which DLB was ruled out initiall...

Full description

Bibliographic Details
Main Authors: Caroline Bouter, Niels Hansen, Charles Timäus, Jens Wiltfang, Claudia Lange
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2020.00684/full
_version_ 1818278783880265728
author Caroline Bouter
Niels Hansen
Charles Timäus
Jens Wiltfang
Jens Wiltfang
Jens Wiltfang
Claudia Lange
author_facet Caroline Bouter
Niels Hansen
Charles Timäus
Jens Wiltfang
Jens Wiltfang
Jens Wiltfang
Claudia Lange
author_sort Caroline Bouter
collection DOAJ
description Dementia with Lewy bodies (DLB) is the second most common form of dementia and is assumed to be often under- or misdiagnosed, especially in early stages. Here we present a complex case of probable DLB with major depression and alcohol and benzodiazepine dependence in which DLB was ruled out initially. This case highlights the challenging diagnostic workup of DLB patients. Core clinical features can be missing and indicative biomarkers can be negative, especially in early stages of the disease. Initially, Fluorodeoxyglucose positron emission tomography as well as neuropsychological assessment were suspicious for a possible DLB diagnosis in our patient while core clinical criteria were missing and the indicative biomarker 123I-FP-CIT SPECT was negative. Follow up was performed two years later and the patients showed several core and supportive clinical features of DLB and 123I-FP-CIT SPECT showed a pathological pattern. Extensive neuropsychological assessment in combination with PET imaging might provide crucial evidence for DLB even in early stages. If neuropsychology and PET imaging point to an early DLB diagnosis careful follow-up should be performed as core symptoms and indicative biomarkers might appear in later stages of the disease.
first_indexed 2024-12-12T23:22:56Z
format Article
id doaj.art-337f5c4f0e9c455f87adf1658745a8e3
institution Directory Open Access Journal
issn 1664-0640
language English
last_indexed 2024-12-12T23:22:56Z
publishDate 2020-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj.art-337f5c4f0e9c455f87adf1658745a8e32022-12-22T00:08:13ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402020-07-011110.3389/fpsyt.2020.00684538966Case Report: The Role of Neuropsychological Assessment and Imaging Biomarkers in the Early Diagnosis of Lewy Body Dementia in a Patient With Major Depression and Prolonged Alcohol and Benzodiazepine DependenceCaroline Bouter0Niels Hansen1Charles Timäus2Jens Wiltfang3Jens Wiltfang4Jens Wiltfang5Claudia Lange6Department of Nuclear Medicine, University Medical Center Göttingen (UMG), Georg-August-University, Goettingen, GermanyDepartment of Psychiatry and Psychotherapy, University Medical Center Göttingen (UMG), Georg-August-University, Goettingen, GermanyDepartment of Psychiatry and Psychotherapy, University Medical Center Göttingen (UMG), Georg-August-University, Goettingen, GermanyDepartment of Psychiatry and Psychotherapy, University Medical Center Göttingen (UMG), Georg-August-University, Goettingen, GermanyGerman Center for Neurodegenerative Diseases (DZNE), Goettingen, GermanyNeurosciences and Signaling Group, Department of Medical Sciences, Institute of Biomedicine (iBiMED), University of Aveiro, Aveiro, PortugalDepartment of Psychiatry and Psychotherapy, University Medical Center Göttingen (UMG), Georg-August-University, Goettingen, GermanyDementia with Lewy bodies (DLB) is the second most common form of dementia and is assumed to be often under- or misdiagnosed, especially in early stages. Here we present a complex case of probable DLB with major depression and alcohol and benzodiazepine dependence in which DLB was ruled out initially. This case highlights the challenging diagnostic workup of DLB patients. Core clinical features can be missing and indicative biomarkers can be negative, especially in early stages of the disease. Initially, Fluorodeoxyglucose positron emission tomography as well as neuropsychological assessment were suspicious for a possible DLB diagnosis in our patient while core clinical criteria were missing and the indicative biomarker 123I-FP-CIT SPECT was negative. Follow up was performed two years later and the patients showed several core and supportive clinical features of DLB and 123I-FP-CIT SPECT showed a pathological pattern. Extensive neuropsychological assessment in combination with PET imaging might provide crucial evidence for DLB even in early stages. If neuropsychology and PET imaging point to an early DLB diagnosis careful follow-up should be performed as core symptoms and indicative biomarkers might appear in later stages of the disease.https://www.frontiersin.org/article/10.3389/fpsyt.2020.00684/fulldementia with Lewy bodies123I-FP-CIT18F-FDG-PETdementiabiomarker
spellingShingle Caroline Bouter
Niels Hansen
Charles Timäus
Jens Wiltfang
Jens Wiltfang
Jens Wiltfang
Claudia Lange
Case Report: The Role of Neuropsychological Assessment and Imaging Biomarkers in the Early Diagnosis of Lewy Body Dementia in a Patient With Major Depression and Prolonged Alcohol and Benzodiazepine Dependence
Frontiers in Psychiatry
dementia with Lewy bodies
123I-FP-CIT
18F-FDG-PET
dementia
biomarker
title Case Report: The Role of Neuropsychological Assessment and Imaging Biomarkers in the Early Diagnosis of Lewy Body Dementia in a Patient With Major Depression and Prolonged Alcohol and Benzodiazepine Dependence
title_full Case Report: The Role of Neuropsychological Assessment and Imaging Biomarkers in the Early Diagnosis of Lewy Body Dementia in a Patient With Major Depression and Prolonged Alcohol and Benzodiazepine Dependence
title_fullStr Case Report: The Role of Neuropsychological Assessment and Imaging Biomarkers in the Early Diagnosis of Lewy Body Dementia in a Patient With Major Depression and Prolonged Alcohol and Benzodiazepine Dependence
title_full_unstemmed Case Report: The Role of Neuropsychological Assessment and Imaging Biomarkers in the Early Diagnosis of Lewy Body Dementia in a Patient With Major Depression and Prolonged Alcohol and Benzodiazepine Dependence
title_short Case Report: The Role of Neuropsychological Assessment and Imaging Biomarkers in the Early Diagnosis of Lewy Body Dementia in a Patient With Major Depression and Prolonged Alcohol and Benzodiazepine Dependence
title_sort case report the role of neuropsychological assessment and imaging biomarkers in the early diagnosis of lewy body dementia in a patient with major depression and prolonged alcohol and benzodiazepine dependence
topic dementia with Lewy bodies
123I-FP-CIT
18F-FDG-PET
dementia
biomarker
url https://www.frontiersin.org/article/10.3389/fpsyt.2020.00684/full
work_keys_str_mv AT carolinebouter casereporttheroleofneuropsychologicalassessmentandimagingbiomarkersintheearlydiagnosisoflewybodydementiainapatientwithmajordepressionandprolongedalcoholandbenzodiazepinedependence
AT nielshansen casereporttheroleofneuropsychologicalassessmentandimagingbiomarkersintheearlydiagnosisoflewybodydementiainapatientwithmajordepressionandprolongedalcoholandbenzodiazepinedependence
AT charlestimaus casereporttheroleofneuropsychologicalassessmentandimagingbiomarkersintheearlydiagnosisoflewybodydementiainapatientwithmajordepressionandprolongedalcoholandbenzodiazepinedependence
AT jenswiltfang casereporttheroleofneuropsychologicalassessmentandimagingbiomarkersintheearlydiagnosisoflewybodydementiainapatientwithmajordepressionandprolongedalcoholandbenzodiazepinedependence
AT jenswiltfang casereporttheroleofneuropsychologicalassessmentandimagingbiomarkersintheearlydiagnosisoflewybodydementiainapatientwithmajordepressionandprolongedalcoholandbenzodiazepinedependence
AT jenswiltfang casereporttheroleofneuropsychologicalassessmentandimagingbiomarkersintheearlydiagnosisoflewybodydementiainapatientwithmajordepressionandprolongedalcoholandbenzodiazepinedependence
AT claudialange casereporttheroleofneuropsychologicalassessmentandimagingbiomarkersintheearlydiagnosisoflewybodydementiainapatientwithmajordepressionandprolongedalcoholandbenzodiazepinedependence